Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 1640282)

Published in J Pediatr on August 01, 1992

Authors

D M Granoff1, E L Anderson, M T Osterholm, S J Holmes, J E McHugh, R B Belshe, F Medley, T V Murphy

Author Affiliations

1: Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.

Articles citing this

Haemophilus influenzae type b conjugate vaccines. Immunology (2004) 1.37

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun (1994) 1.35

Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborative Vaccine Study Group. J Clin Invest (1993) 1.23

Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect Immun (2005) 1.21

Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun (1994) 1.05

Conjugate vaccines. Clin Exp Immunol (2000) 1.01

Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants. BMJ (1996) 0.98

The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infect Immun (1997) 0.93

Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun (1994) 0.92

Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother (2013) 0.89

Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. J Clin Pathol (1995) 0.86

A strategy for rational design of fully synthetic glycopeptide conjugate vaccines. Infect Immun (1997) 0.85

Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine. Clin Diagn Lab Immunol (2005) 0.83

Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali. Am J Trop Med Hyg (2012) 0.82

Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. Emerg Infect Dis (2012) 0.81

The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants. Infect Immun (1995) 0.80

Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria. J Clin Pathol (2004) 0.80

Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. Vaccine (2011) 0.78

Evaluation of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) in Canadian infants. Can J Infect Dis (1994) 0.75

Articles by these authors

Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23

Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med (1999) 6.20

Audit: an annual assessment of the work and performance of a surgical firm in a regional teaching hospital. Br Med J (1980) 5.55

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis (1996) 5.14

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis (2001) 5.07

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49

A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team. N Engl J Med (1996) 4.14

Infectious disease surveillance: a crumbling foundation. Science (1994) 3.89

Air pollution and daily mortality in Philadelphia. Epidemiology (1995) 3.85

A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis (1985) 3.81

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53

Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis (1998) 3.52

Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27

Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med (1989) 3.16

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05

An outbreak of foodborne giardiasis. N Engl J Med (1981) 2.98

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis (2000) 2.90

Cyclosporiasis and raspberries--lessons for the future. N Engl J Med (1997) 2.86

Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med (1997) 2.63

Changing epidemiology of food-borne disease: a Minnesota perspective. Clin Infect Dis (1994) 2.53

An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52

The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med (1990) 2.37

Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA (1994) 2.31

Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics (1995) 2.20

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis (1982) 2.17

An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis (1997) 2.10

Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06

Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA (1993) 2.05

Meningococcal disease and public health practice: a complicated road map. JAMA (1998) 2.03

Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infect Immun (1978) 1.96

A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med (1996) 1.96

Infectious diseases in competitive sports. JAMA (1994) 1.92

The public health information infrastructure. A national review of the law on health information privacy. JAMA (1996) 1.91

Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA (1993) 1.91

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84

An outbreak of nitrogen dioxide-induced respiratory illness among ice hockey players. JAMA (1989) 1.83

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis (1995) 1.83

An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med (1991) 1.80

An international foodborne outbreak of shigellosis associated with a commercial airline. JAMA (1992) 1.79

Experimental respiratory syncytial virus infection of four species of primates. J Med Virol (1977) 1.74

Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med (1982) 1.73

Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis (1982) 1.70

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics (2001) 1.70

Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med (1984) 1.69

Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med (1990) 1.69

Campylobacter enteritis outbreaks associated with drinking raw milk during youth activities. A 10-year review of outbreaks in the United States. JAMA (1992) 1.69

Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr (1993) 1.69

Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA (1987) 1.69

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67

Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? N Engl J Med (1985) 1.65

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis (1993) 1.62

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61

Irradiation pasteurization of solid foods: taking food safety to the next level. Emerg Infect Dis (1997) 1.61

Air pollution and hospital admissions for respiratory causes in Minneapolis-St. Paul and Birmingham. Epidemiology (1997) 1.59

Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis (1988) 1.58

Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis (1998) 1.58

The influence of childhood disciplinary experience on the development of alcoholism and depression. J Child Psychol Psychiatry (1987) 1.56

Role of egg consumption in sporadic Salmonella enteritidis and Salmonella typhimurium infections in Minnesota. J Infect Dis (1993) 1.56

Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother (1975) 1.56

Immunoglobulin M-specific serologic testing in an outbreak of foodborne viral hepatitis, type A. Am J Epidemiol (1980) 1.55

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res (1992) 1.51

Palmitoylation of the influenza A virus M2 protein. Virology (1990) 1.51

An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis (1987) 1.50

Serologic study of two clusters of infection due to Campylobacter jejuni. J Infect Dis (1983) 1.49

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47

Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients. Pediatr Infect Dis J (1987) 1.47

An outbreak of Escherichia coli O157:H7 colitis associated with consumption of precooked meat patties. J Infect Dis (1991) 1.44

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother (1991) 1.43

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med (1991) 1.43

A multistate outbreak of Salmonella javiana and Salmonella oranienburg infections due to consumption of contaminated cheese. JAMA (1992) 1.43

Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein. Lancet (1986) 1.42

Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J Med Virol (1978) 1.42

Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA (1995) 1.40

Melittin lysis of red cells. J Membr Biol (1985) 1.40

Use of molecular subtyping in surveillance for Salmonella enterica serotype typhimurium. N Engl J Med (2001) 1.39

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine (2000) 1.38

Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. N Engl J Med (1986) 1.36

Outbreaks of salmonellosis associated with eating uncooked tomatoes: implications for public health. The Investigation Team. Epidemiol Infect (1999) 1.36

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis (1995) 1.36

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun (1994) 1.35

Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Antimicrob Agents Chemother (1990) 1.35

Radiation pneumonitis and fibrosis in mouse lung assayed by respiratory frequency and histology. Radiat Res (1980) 1.34

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis (1998) 1.33

Norwalk gastroenteritis: a community outbreak associated with bakery product consumption. Ann Intern Med (1984) 1.33

Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol (1991) 1.32